Individualised target hormone levels need to be established before commercial hormonal panel testing can guide therapy, experts say. (This image is human-created, AI-aided)
Many direct-to-consumer menopause services are unnecessary and do not improve care, warned experts in The BMJ medical journal on Aug 20 (2025).
They argue that the sharp rise in commercial services for women seeking relief for menopausal symptoms raises concerns about the reliability and potential commercial bias of the information.
